1,301
Views
13
CrossRef citations to date
0
Altmetric
Review Articles

Mycobacterium tuberculosis extracellular vesicles: exploitation for vaccine technology and diagnostic methods

, ORCID Icon, & ORCID Icon
Pages 13-33 | Received 22 May 2020, Accepted 26 Sep 2020, Published online: 12 Oct 2020

References

  • Aagaard C, Hoang T, Dietrich J, Cardona P-J, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med. 17(2):189–194.
  • Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 169(6):3155–3162.
  • Alaniz RC, Deatherage BL, Lara JC, Cookson BT. 2007. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol. 179(11):7692–7701.
  • Alvarez ML, Khosroheidari M, Ravi RK, DiStefano JK. 2012. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 82(9):1024–1032.
  • Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 29(4):341–345.
  • Alves NJ, Turner KB, Daniele MA, Oh E, Medintz IL, Walper SA. 2015. Bacterial nanobioreactors-directing enzyme packaging into bacterial outer membrane vesicles. ACS Appl Mater Interfaces. 7(44):24963–24972.
  • Andaloussi SE, Mäger I, Breakefield XO, Wood MJ. 2013. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 12(5):347–357.
  • Armstrong JP, Stevens MM. 2018. Strategic design of extracellular vesicle drug delivery systems. Adv Drug Deliv Rev. 130:12–16.
  • Athman JJ, Sande OJ, Groft SG, Reba SM, Nagy N, Wearsch PA, Richardson ET, Rojas R, Boom WH, Shukla S, et al. 2017. Mycobacterium tuberculosis membrane vesicles inhibit T cell activation. J Immunol. 198(5):2028–2037.
  • Athman JJ, Wang Y, McDonald DJ, Boom WH, Harding CV, Wearsch PA. 2015. Bacterial membrane vesicles mediate the release of Mycobacterium tuberculosis lipoglycans and lipoproteins from infected macrophages. J Immunol. 195(3):1044–1053.
  • Bachmann MF, Jennings GT. 2010. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 10(11):787–796.
  • Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med. 202(12):1715–1724.
  • Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Berlanda Scorza F, Norais N, Laera D, Giusti F, Pierleoni A, et al. 2013. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles. 2(1):20181.
  • Beveridge TJ. 1999. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol. 181(16):4725–4733.
  • Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS. 2007. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood. 110:3234–3244.
  • Billker O, Popp A, Gray-Owen SD, Meyer TF. 2000. The structural basis of CEACAM-receptor targeting by neisserial Opa proteins. Trends Microbiol. 8(6):258–260.
  • Bobrie A, Colombo M, Krumeich S, Raposo G, Théry C. 2012. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J Extracell Vesicles. 1(1):18397.
  • Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, et al. 2011. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 377(9776):1495–1505.
  • Brennan MJ, Thole J. 2012. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis. 92:S6–S13.
  • Brett SI, Lucien F, Guo C, Williams KC, Kim Y, Durfee PN, Brinker C, Chin JI, Yang J, Leong HS. 2017. Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples. Prostate. 77(13):1335–1343.
  • Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285(5428):732–736.
  • Brodsky IE, Ghori N, Falkow S, Monack D. 2005. Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol Microbiol. 55(3):954–972.
  • Brown L, Kessler A, Cabezas‐Sanchez P, Luque‐Garcia JL, Casadevall A. 2014. Extracellular vesicles produced by the Gram-positive bacterium Bacillus subtilis are disrupted by the lipopeptide surfactin . Mol Microbiol. 93(1):183–198.
  • Brown L, Wolf JM, Prados-Rosales R, Casadevall A. 2015. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol. 13(10):620–630.
  • Brune KD, Leneghan DB, Brian IJ, Ishizuka AS, Bachmann MF, Draper SJ, Biswas S, Howarth M. 2016. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization. Sci Rep. 6:19234.
  • Burgio S, Noori L, Marino Gammazza A, Campanella C, Logozzi M, Fais S, Bucchieri F, Cappello F, Caruso Bavisotto C. 2020. Extracellular vesicles-based drug delivery systems: a new challenge and the exemplum of malignant pleural mesothelioma. IJMS. 21(15):5432.
  • Buzás EI, Gardiner C, Lee C, Smith ZJ. 2017. Single particle analysis: methods for detection of platelet extracellular vesicles in suspension (excluding flow cytometry). Platelets. 28(3):249–255.
  • Calmette A. 1927. Sur la vaccination préventive des infants nouveau-nés contre la tuberculose par le BCG. Ann Inst Pasteur. 41:201–232.
  • Chatterjee S, Das J. 1967. Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae. J Gen Microbiol. 49(1):1–11.
  • Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, Putnam D. 2010. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci USA. 107(7):3099–3104.
  • Cheng Y, Schorey JS. 2013. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection. Eur J Immunol. 43(12):3279–3290.
  • Cheng Y, Schorey JS. 2016. Targeting soluble proteins to exosomes using a ubiquitin tag. Biotechnol Bioeng. 113(6):1315–1324.
  • Choi J-W, Um J-H, Cho J-H, Lee H-J. 2017. Tiny RNAs and their voyage via extracellular vesicles: secretion of bacterial small RNA and eukaryotic microRNA. Exp Biol Med. 242(15):1475–1481.
  • Chutkan H, MacDonald I, Manning A, Kuehn MJ. 2013. Quantitative and qualitative preparations of bacterial outer membrane vesicles Bacterial Cell Surfaces. Methods Mol Biol. 966:259–272.
  • Coffman RL, Sher A, Seder RA. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity. 33(4):492–503.
  • Costa I, Pajon R, Granoff DM. 2014. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. MBio. 5(5).
  • Daffé M. 2015. The cell envelope of tubercle bacilli. Tuberculosis. 95:S155–S158.
  • Daleke-Schermerhorn MH, Felix T, Soprova Z, Ten Hagen-Jongman CM, Vikström D, Majlessi L, Beskers J, Follmann F, de Punder K, van der Wel NN, et al. 2014. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach. Appl Environ Microbiol. 80(18):5854–5865.
  • Dauros Singorenko P, Chang V, Whitcombe A, Simonov D, Hong J, Phillips A, Swift S, Blenkiron C. 2017. Isolation of membrane vesicles from prokaryotes: a technical and biological comparison reveals heterogeneity. J Extracell Vesicles. 6(1):1324731.
  • Deatherage BL, Cookson BT. 2012. Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life. Infect Immun. 80(6):1948–1957.
  • Deatherage BL, Lara JC, Bergsbaken T, Barrett SLR, Lara S, Cookson BT. 2009. Biogenesis of bacterial membrane vesicles. Mol Microbiol. 72(6):1395–1407.
  • Diaz G, Wolfe LM, Kruh-Garcia NA, Dobos KM. 2016. Changes in the membrane-associated proteins of exosomes released from human macrophages after Mycobacterium tuberculosis infection. Sci Rep. 6:37975
  • Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV. 2009. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol. 258(1):29–37.
  • Drage MG, Tsai H-C, Pecora ND, Cheng T-Y, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, et al. 2010. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol. 17(9):1088–1095.
  • Elhenawy W, Debelyy MO, Feldman MF. 2014. Preferential packing of acidic glycosidases and proteases into Bacteroides outer membrane vesicles. MBio. 5(2):e00909–e00914.
  • Ellis TN, Kuehn MJ. 2010. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 74(1):81–94.
  • Fantappiè L, De Santis M, Chiarot E, Carboni F, Bensi G, Jousson O, Margarit I, Grandi G. 2014. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. J Extracell Vesicles. 3(1):24015.
  • Farsiani H, Mosavat A, Soleimanpour S, Sadeghian H, Eydgahi MRA, Ghazvini K, Sankian M, Aryan E, Jamehdar SA, Rezaee SA. 2016. Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex. Mol Biosyst. 12(7):2189–2201.
  • Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF. 2010. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 11(5):675–687.
  • Fransen F, Stenger RM, Poelen MC, Van Dijken HH, Kuipers B, Boog CJ, Van Putten JP, van Els CA, van der Ley P. 2010. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One. 5(12):e15692.
  • Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V. 2001. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol. 154(3):631–644.
  • Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. 2015. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 205:35–44.
  • Galen JE, Curtiss R. 2014. The delicate balance in genetically engineering live vaccines. Vaccine. 32(35):4376–4385.
  • Gamazo C, Moriyon I. 1987. Release of outer membrane fragments by exponentially growing Brucella melitensis cells. Infect Immun. 55(3):609–615.
  • Gao J, Chu D, Wang Z. 2016. Cell membrane-formed nanovesicles for disease-targeted delivery. J Control Release. 224:208–216.
  • Gao J, Wang S, Wang Z. 2017. High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. Biomaterials. 135:62–73.
  • Gao W, Fang RH, Thamphiwatana S, Luk BT, Li J, Angsantikul P, Zhang Q, Hu C-MJ, Zhang L. 2015. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett. 15(2):1403–1409.
  • Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. 2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 173(4):2660–2668.
  • Gerritzen MJ, Martens DE, Wijffels RH, van der Pol L, Stork M. 2017. Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnol Adv. 35(5):565–574.
  • Giri PK, Kruh NA, Dobos KM, Schorey JS. 2010. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages . Proteomics. 10(17):3190–3202.
  • Giri PK, Schorey JS. 2008. Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS One. 3(6):e2461.
  • Gujrati V, Kim S, Kim S-H, Min JJ, Choy HE, Kim SC, Jon S. 2014. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano. 8(2):1525–1537.
  • Gupta S, Rodriguez GM. 2018. Mycobacterial extracellular vesicles and host pathogen interactions. Pathog Dis. 76(4):fty031.
  • Gutiérrez ‐Vázquez C, Villarroya ‐Beltri C, Mittelbrunn M, Sánchez ‐ Madrid F. 2013. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev. 251(1):125–142.
  • György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al. 2011. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 68(16):2667–2688.
  • Harding CV, Boom WH. 2010. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 8(4):296–307.
  • Haurat MF, Aduse-Opoku J, Rangarajan M, Dorobantu L, Gray MR, Curtis MA, Feldman MF. 2011. Selective sorting of cargo proteins into bacterial membrane vesicles. J Biol Chem. 286(2):1269–1276.
  • Hesseling A, Johnson L, Jaspan H, Cotton M, Whitelaw A, Schaaf H, Fine P, Eley B, Marais B, Nuttall J. 2009. Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Org. 87(7):505–511.
  • Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N. 2007. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine. 25(1):14–18.
  • Hoekstra D, van der Laan JW, de Leij L, Witholt B. 1976. Release of outer membrane fragments from normally growing Escherichia coli. Biochimica et Biophysica Acta (BBA)-Biomembranes. 455(3):889–899.
  • Holst J, Martin D, Arnold R, Huergo CC, Oster P, O’Hallahan J, Rosenqvist E. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine. 27:B3–B12.
  • Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, Lee H. 2014. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 32(5):490–495.
  • Jäger J, Keese S, Roessle M, Steinert M, Schromm AB. 2015. Fusion of Legionella pneumophila outer membrane vesicles with eukaryotic membrane systems is a mechanism to deliver pathogen factors to host cell membranes. Cell Microbiol. 17(5):607–620.
  • Jarlier V, Nikaido H. 1990. Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J Bacteriol. 172(3):1418–1423.
  • Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M. 2014. A comprehensive overview of exosomes as drug delivery vehicles – endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta. 1846(1):75–87.
  • Jurkoshek KS, Wang Y, Athman JJ, Barton MR, Wearsch PA. 2016. Interspecies communication between pathogens and immune cells via bacterial membrane vesicles. Front Cell Dev Biol. 4:125
  • Kadurugamuwa JL, Beveridge TJ. 1995. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol. 177(14):3998–4008.
  • Kalluri R. 2016. The biology and function of exosomes in cancer. J Clin Invest. 126(4):1208–1215.
  • Kaparakis-Liaskos M, Ferrero RL. 2015. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 15(6):375–387.
  • Kaufmann SH. 2006. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol. 6(9):699–704.
  • Kaufmann SH. 2010. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity. 33(4):567–577.
  • Kesty NC, Kuehn MJ. 2004. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem. 279(3):2069–2076.
  • Kim J-Y, Doody AM, Chen DJ, Cremona GH, Shuler ML, Putnam D, DeLisa MP. 2008. Engineered bacterial outer membrane vesicles with enhanced functionality. J Mol Biol. 380(1):51–66.
  • Kim OY, Hong BS, Park K-S, Yoon YJ, Choi SJ, Lee WH, Roh T-Y, Lötvall J, Kim Y-K, Gho YS. 2013. Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses. J Immunol. 190(8):4092–4102.
  • Kim S-H, Kim K-S, Lee S-R, Kim E, Kim M-S, Lee E-Y, Gho YS, Kim J-W, Bishop RE, Chang K-T. 2009. Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta. 1788(10):2150–2159.
  • Koyama Y, Ito T, Hasegawa A, Eriguchi M, Inaba T, Ushigusa T, Sugiura K. 2016. Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy. Biotechnol Lett. 38(11):1857–1866.
  • Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, Davis JL, Dobos KM. 2014. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. PLoS One. 9(7):e103811.
  • Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19(22):2645–2655.
  • Kulp A, Kuehn MJ. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol. 64:163–184.
  • Kumar S, Anselmo AC, Banerjee A, Zakrewsky M, Mitragotri S. 2015. Shape and size-dependent immune response to antigen-carrying nanoparticles. J Control Release. 220(Pt A):141–148.
  • Kurthkoti K, Amin H, Marakalala MJ, Ghanny S, Subbian S, Sakatos A, Livny J, Fortune SM, Berney M, Rodriguez GM. 2017. The capacity of Mycobacterium tuberculosis to survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas. MBio. 8(4):e01092.
  • Lai CH, Listgarten MA, Hammond BF. 1981. Comparative ultrastructure of leukotoxic and non-leukotoxic strains of Actinobacillus actinomycetemcomitans. J Periodont Res. 16(4):379–389.
  • Lamichhane TN, Raiker RS, Jay SM. 2015. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm. 12(10):3650–3657.
  • Lancioni CL, Li Q, Thomas JJ, Ding X, Thiel B, Drage MG, Pecora ND, Ziady AG, Shank S, Harding CV, et al. 2011. Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2. Infect Immun. 79(2):663–673.
  • Lee E-Y, Choi D-Y, Kim D-K, Kim J-W, Park JO, Kim S, Kim S-H, Desiderio DM, Kim Y-K, Kim K-P, et al. 2009. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles . Proteomics. 9(24):5425–5436.
  • Lee J, Kim S-H, Choi D-S, Lee JS, Kim D-K, Go G, Park S-M, Kim SH, Shin JH, Chang CL, et al. 2015. Proteomic analysis of extracellular vesicles derived from Mycobacterium tuberculosis. Proteomics. 15(19):3331–3337.
  • Lee K, Shao H, Weissleder R, Lee H. 2015. Acoustic purification of extracellular microvesicles. ACS Nano. 9(3):2321–2327.
  • Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, et al. 2015. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 4:30087
  • Liu C, Feng Q, Sun J. 2019. Lipid nanovesicles by microfluidics: manipulation, synthesis, and drug delivery. Adv Mater. 31:1804788.
  • Loeb MR. 1974. Bacteriophage T4-mediated release of envelope components from Escherichia coli. J Virol. 13(3):631–641.
  • Luirink J, Jong WS. 2016. Fusion protein for secretory protein expression: Google Patents. Xbrane Bioscience Ab. WO/2012/041899.
  • Lyons AB, Parish CR. 1994. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 171(1):131–137.
  • Machtinger R, Laurent LC, Baccarelli AA. 2016. Extracellular vesicles: roles in gamete maturation, fertilization and embryo implantation. Hum Reprod Update. 22(2):182–193.
  • Maertzdorf J, Weiner IIJ, Kaufmann S. 2012. Enabling biomarkers for tuberculosis control [State of the Art Series. New tools. Number 3 in the series]. Int J Tuberc Lung Dis. 16(9):1140–1148.
  • Mahon RN, Rojas RE, Fulton SA, Franko JL, Harding CV, Boom WH. 2009. Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling. Infect Immun. 77(10):4574–4583.
  • Mahon RN, Sande OJ, Rojas RE, Levine AD, Harding CV, Boom WH. 2012. Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation. Cell Immunol. 275(1–2):98–105.
  • Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. 2008. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol. 38(5):1404–1413.
  • Marshall HS, Richmond PC, Nissen MD, Wouters A, Baber J, Jiang Q, Anderson AS, Jones TR, Harris SL, Jansen KU, et al. 2013. A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine. 31(12):1569–1575.
  • Marsollier L, Brodin P, Jackson M, Korduláková J, Tafelmeyer P, Carbonnelle E, Aubry J, Milon G, Legras P, André J-PS, et al. 2007. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog. 3(5):e62.
  • Mashburn LM, Whiteley M. 2005. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature. 437(7057):422–425.
  • Mathieu M, Martin-Jaular L, Lavieu G, Thery C. 2019. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 21(1):9–17.
  • Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, Kugler D, Hieny S, Caspar P, Núñez G, et al. 2010. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. 184(7):3326–3330.
  • McBroom AJ, Kuehn MJ. 2007. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol. 63(2):545–558.
  • McConnell MJ, Rumbo C, Bou G, Pachón J. 2011. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine. 29(34):5705–5710.
  • McLeod E, Dincer TU, Veli M, Ertas YN, Nguyen C, Luo W, Greenbaum A, Feizi A, Ozcan A. 2015. High-throughput and label-free single nanoparticle sizing based on time-resolved on-chip microscopy. ACS Nano. 9(3):3265–3273.
  • McMahon KJ, Castelli ME, Vescovi EG, Feldman MF. 2012. Biogenesis of outer membrane vesicles in Serratia marcescens is thermoregulated and can be induced by activation of the Rcs phosphorelay system. J Bacteriol. 194(12):3241–3249.
  • Mehaffy C, Dobos KM, Nahid P, Kruh-Garcia NA. 2017. Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum. Clin Proteom. 14(1):10.
  • Mitra S, Sinha R, Mitobe J, Koley H. 2016. Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain. Vaccine. 34(15):1839–1846.
  • Moon DC, Choi CH, Lee JH, Choi C-W, Kim H-Y, Park JS, Kim SI, Lee JC. 2012. Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles. J Microbiol. 50(1):155–160.
  • Muralinath M, Kuehn MJ, Roland KL, Curtiss R. 2011. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun. 79(2):887–894.
  • Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, et al. 2012. Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis. 205(suppl_2):S159–S168.
  • Namork E, Brandtzaeg P. 2002. Fatal meningococcal septicaemia with “blebbing” meningococcus. Lancet. 360(9347):1741.
  • Nawaz M, Malik MI, Hameed M, Zhou J. 2019. Research progress on the composition and function of parasite-derived exosomes. Acta Trop. 196:30–36.
  • Nieves W, Asakrah S, Qazi O, Brown KA, Kurtz J, AuCoin DP, McLachlan JB, Roy CJ, Morici LA. 2011. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine. 29(46):8381–8389.
  • Nieves W, Heang J, Asakrah S, Zu Bentrup KH, Roy CJ, Morici LA. 2010. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS One. 5(12):e14361
  • Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol. 166(12):7477–7485.
  • O'donoghue EJ, Krachler AM. 2016. Mechanisms of outer membrane vesicle entry into host cells. Cell Microbiol. 18(11):1508–1517.
  • Ohno S-i, Ishikawa A, Kuroda M. 2013. Roles of exosomes and microvesicles in disease pathogenesis. Adv Drug Deliv Rev. 65(3):398–401.
  • Olaya-Abril A, Prados-Rosales R, McConnell MJ, Martín-Peña R, González-Reyes JA, Jiménez-Munguía I, Gómez-Gascón L, Fernández J, Luque-García JL, García-Lidón C, et al. 2014. Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae. J Proteomics. 106:46–60.
  • Parisse P, Rago I, Ulloa Severino L, Perissinotto F, Ambrosetti E, Paoletti P, Ricci M, Beltrami AP, Cesselli D, Casalis L. 2017. Atomic force microscopy analysis of extracellular vesicles. Eur Biophys J. 46(8):813–820.
  • Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, et al. 2009. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 284(49):34211–34222.
  • Pathirana RD, Kaparakis-Liaskos M. 2016. Bacterial membrane vesicles: biogenesis, immune regulation and pathogenesis. Cell Microbiol. 18(11):1518–1524.
  • Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. 2006. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol. 177(1):422–429.
  • Platt M, Willmott GR, Lee GU. 2012. Resistive pulse sensing of analyte-induced multicomponent rod aggregation using tunable pores . Small. 8(15):2436–2444.
  • Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U, Camara C, Nosanchuk JD, Besra GS, Chen B, et al. 2011. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest. 121(4):1471–1483.
  • Prados-Rosales R, Brown L, Casadevall A, Montalvo-Quirós S, Luque-Garcia JL. 2014a. Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria. MethodsX. 1:124–129.
  • Prados-Rosales R, Carreño LJ, Batista-Gonzalez A, Baena A, Venkataswamy MM, Xu J, Yu X, Wallstrom G, Magee DM, LaBaer J, et al. 2014b. Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis. MBio. 5(5):e01921–14.
  • Prados-Rosales R, Weinrick BC, Piqué DG, Jacobs WR, Casadevall A, Rodriguez GM. 2014c. Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition. J Bacteriol. 196(6):1250–1256.
  • Pritsch M, Ben-Khaled N, Chaloupka M, Kobold S, Berens-Riha N, Peter A, Liegl G, Schubert S, Hoelscher M, Löscher T, et al. 2016. Comparison of intranasal outer membrane vesicles with cholera toxin and injected MF59C. 1 as adjuvants for malaria transmission blocking antigens AnAPN1 and Pfs48/45. J Immunol Res. 2016:3576028
  • Ramachandra L, Qu Y, Wang Y, Lewis CJ, Cobb BA, Takatsu K, Boom WH, Dubyak GR, Harding CV. 2010. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect Immun. 78(12):5116–5125.
  • Rath P, Huang C, Wang T, Wang T, Li H, Prados-Rosales R, Elemento O, Casadevall A, Nathan CF. 2013. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 110(49):E4790–E4797.
  • Reba SM, Li Q, Onwuzulike S, Ding X, Karim AF, Hernandez Y, Fulton SA, Harding CV, Lancioni CL, Nagy N, et al. 2014. TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis. Eur J Immunol. 44(5):1410–1421.
  • Ricci V, Chiozzi V, Necchi V, Oldani A, Romano M, Solcia E, Ventura U. 2005. Free-soluble and outer membrane vesicle-associated VacA from Helicobacter pylori: two forms of release, a different activity. Biochem Biophys Res Commun. 337(1):173–178.
  • Richardson ET, Shukla S, Sweet DR, Wearsch PA, Tsichlis PN, Boom WH, Harding CV. 2015. TLR2-dependent ERK signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells. Infect Immun. 83(6):2242–2254.
  • Rider MA, Hurwitz SN, Meckes DG. Jr 2016. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci Rep. 6:23978.
  • Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. 2010. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc Natl Acad Sci USA. 107(44):19002–19007.
  • Robbins PD, Morelli AE. 2014. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 14(3):195–208.
  • Rodriguez GM, Prados-Rosales R. 2016. Functions and importance of mycobacterial extracellular vesicles. Appl Microbiol Biotechnol. 100(9):3887–3892.
  • Rodriguez L, Tirado Y, Reyes F, Puig A, Kadir R, Borrero R, Fernandez S, Reyes G, Alvarez N, Garcia MA, et al. 2011. Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice. Vaccine. 29(37):6236–6241.
  • Roier S, Zingl FG, Cakar F, Durakovic S, Kohl P, Eichmann TO, Klug L, Gadermaier B, Weinzerl K, Prassl R, et al. 2016. A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria. Nat Commun. 7:10515.
  • Rosenthal JA, Huang C-J, Doody AM, Leung T, Mineta K, Feng DD, Wayne EC, Nishimura N, Leifer C, DeLisa MP, et al. 2014. Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles. PLoS One. 9(11):e112802
  • Rossi R, Granoff DM, Beernink PT. 2013. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice. Vaccine. 31(46):5451–5457.
  • Rylance J, Pai M, Lienhardt C, Garner P. 2010. Priorities for tuberculosis research: a systematic review. Lancet Infect Dis. 10(12):886–892.
  • Salverda ML, Meinderts SM, Hamstra H-J, Wagemakers A, Hovius JW, van der Ark A, Stork M, van der Ley P. 2016. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles. Vaccine. 34(8):1025–1033.
  • Sande OJ, Karim AF, Li Q, Ding X, Harding CV, Rojas RE, Boom WH. 2016. Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis induces CD4+ T cell anergy via GRAIL. J Immunol. 196(2):691–702.
  • Schertzer JW, Whiteley M. 2012. A bilayer-couple model of bacterial outer membrane vesicle biogenesis. MBio. 3(2):e00297.
  • Schild S, Nelson EJ, Bishop AL, Camilli A. 2009. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun. 77(1):472–484.
  • Schild S, Nelson EJ, Camilli A. 2008. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun. 76(10):4554–4563.
  • Schlesinger LS, Hull SR, Kaufman TM. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol. 152(8):4070–4079.
  • Schooling SR, Beveridge TJ. 2006. Membrane vesicles: an overlooked component of the matrices of biofilms. J Bacteriol. 188(16):5945–5957.
  • Schorey JS, Harding CV. 2016. Extracellular vesicles and infectious diseases: new complexity to an old story. J Clin Invest. 126(4):1181–1189.
  • Schwechheimer C, Kuehn MJ. 2013. Synthetic effect between envelope stress and lack of outer membrane vesicle production in Escherichia coli. J Bacteriol. 195(18):4161–4173.
  • Schwechheimer C, Kulp A, Kuehn MJ. 2014. Modulation of bacterial outer membrane vesicle production by envelope structure and content. BMC Microbiol. 14:324
  • Schwechheimer C, Rodriguez DL, Kuehn MJ. 2015. NlpI-mediated modulation of outer membrane vesicle production through peptidoglycan dynamics in Escherichia coli. Microbiologyopen. 4(3):375–389.
  • Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. 2012. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine. 30:B87–B97.
  • Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, Hochberg FH, Breakefield XO, Weissleder R, Lee H. 2012. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 18(12):1835–1840.
  • Shockman GD, Barrett JF. 1983. Structure, function, and assembly of cell walls of gram-positive bacteria. Annu Rev Microbiol. 37:501–527.
  • Siddiqi K, Lambert M-L, Walley J. 2003. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 3(5):288–296.
  • Simmons DP, Canaday DH, Liu Y, Li Q, Huang A, Boom WH, Harding CV. 2010. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol. 185(4):2405–2415.
  • Simpson RJ, Lim JW, Moritz RL, Mathivanan S. 2009. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics. 6(3):267–283.
  • Singh M, Chakrapani A, O'Hagan D. 2007. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines. 6(5):797–808.
  • Singh PP, Smith VL, Karakousis PC, Schorey JS. 2012. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol. 189(2):777–785.
  • Smith VL, Jackson L, Schorey JS. 2015. Ubiquitination as a mechanism to transport soluble mycobacterial and eukaryotic proteins to exosomes. J Immunol. 195(6):2722–2730.
  • Society AT. 2000. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 161:1376–1395.
  • Soleimanpour S, Farsiani H, Mosavat A, Ghazvini K, Eydgahi MRA, Sankian M, Sadeghian H, Meshkat Z, Rezaee SA. 2015. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Appl Microbiol Biotechnol. 99(24):10467–10480.
  • Soo CY, Song Y, Zheng Y, Campbell EC, Riches AC, Gunn ‐Moore F, Powis SJ. 2012. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology. 136(2):192–197.
  • Steingart KR, Dendukuri N, Henry M, Schiller I, Nahid P, Hopewell PC, Ramsay A, Pai M, Laal S. 2009. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol. 16(2):260–276.
  • Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, Urbanczik R, Perkins M, Aziz MA, Pai M. 2006. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 6(9):570–581.
  • Suchorska WM, Lach MS. 2016. The role of exosomes in tumor progression and metastasis (Review). Oncol Rep. 35(3):1237–1244.
  • Sugawara I, Yamada H, Li C, Mizuno S, Takeuchi O, Akira S. 2003. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol. 47(5):327–336.
  • Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, Mörgelin M, Belting M. 2013. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem. 288(24):17713–17724.
  • Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, Simpson RJ. 2012. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 56(2):293–304.
  • Technology HUoSa. 2013. Safety and effectiveness study of tumor cell-derived microparticles to treat malignant ascites and pleural effusion. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). [Retrieved July, 2013]. (NLMIdentifier: NCT01854866). https://clinicaltrials.gov/ct2/show/NCT01854866.
  • Thay B, Wai SN, Oscarsson J. 2013. Staphylococcus aureus α-toxin-dependent induction of host cell death by membrane-derived vesicles. PLoS One. 8(1):e54661
  • Théry C, Ostrowski M, Segura E. 2009. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 9(8):581–593.
  • Tian T, Zhu Y-L, Zhou Y-Y, Liang G-F, Wang Y-Y, Hu F-H, Xiao Z-D. 2014. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 289(32):22258–22267.
  • Trunz BB, Fine P, Dye C. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 367(9517):1173–1180.
  • Turner L, Praszkier J, Hutton ML, Steer D, Ramm G, Kaparakis ‐Liaskos M, Ferrero RL. 2015. Increased outer membrane vesicle formation in a Helicobacter pylori tolB mutant. Helicobacter. 20(4):269–283.
  • Vaidyanathan R, Naghibosadat M, Rauf S, Korbie D, Carrascosa LG, Shiddiky MJ, Trau M. 2014. Detecting exosomes specifically: a multiplexed device based on alternating current electrohydrodynamic induced nanoshearing. Anal Chem. 86(22):11125–11132.
  • van der Meel R, Fens MH, Vader P, Van Solinge WW, Eniola-Adefeso O, Schiffelers RM. 2014. Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release. 195:72–85.
  • Van Der Pol E, Hoekstra A, Sturk A, Otto C, Van Leeuwen T, Nieuwland R. 2010. Optical and non-optical methods for detection and characterization of microparticles and exosomes . J Thromb Haemost. 8(12):2596–2607.
  • van der Pol L, Stork M, van der Ley P. 2015. Outer membrane vesicles as platform vaccine technology. Biotechnol J. 10(11):1689–1706.
  • Van Dongen HM, Masoumi N, Witwer KW, Pegtel DM. 2016. Extracellular vesicles exploit viral entry routes for cargo delivery. Microbiol Mol Biol Rev. 80(2):369–386.
  • Verdera HC, Gitz-Francois JJ, Schiffelers RM, Vader P. 2017. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. J Control Release. 266:100–108.
  • Vergne I, Chua J, Deretic V. 2003. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J Exp Med. 198(4):653–659.
  • Vlassov AV, Magdaleno S, Setterquist R, Conrad R. 2012. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 1820(7):940–948.
  • Wai SN, Takade A, Amako K. 1995. The release of outer membrane vesicles from the strains of enterotoxigenic Escherichia coli. Microbiol Immunol. 39(7):451–456.
  • Wang J, Wang Y, Tang L, Garcia RC. 2019. Extracellular vesicles in mycobacterial infections: their potential as molecule transfer vectors. Front Immunol. 10:1929.
  • Wang S, Gao J, Wang Z. 2019. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 11(2):e1523.
  • Welsh JA, Holloway JA, Wilkinson JS, Englyst NA. 2017. Extracellular vesicle flow cytometry analysis and standardization. Front Cell Dev Biol. 5:78
  • Wessel AK, Liew J, Kwon T, Marcotte EM, Whiteley M. 2013. Role of Pseudomonas aeruginosa peptidoglycan-associated outer membrane proteins in vesicle formation. J Bacteriol. 195(2):213–219.
  • White DW, Elliott SR, Odean E, Bemis LT, Tischler AD. 2018. Mycobacterium tuberculosis Pst/SenX3-RegX3 regulates membrane vesicle production independently of ESX-5 activity. MBio. 9(3):e00778.
  • WHO. 2013. Global tuberculosis report 2013. World Health Organization. https://apps.who.int/iris/handle/10665/91355.
  • Wiklander OP, Brennan MÁ, Lötvall J, Breakefield XO, Andaloussi SE. 2019. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. 11(492):eaav8521.
  • Wiklander OPB, Nordin JZ, O'Loughlin A, Gustafsson Y, Corso G, Mäger I, Vader P, Lee Y, Sork H, Seow Y, et al. 2015. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 4(1):26316.
  • Wolf JM, Rivera J, Casadevall A. 2012. Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles. Cell Microbiol. 14(5):762–773.
  • Yang B, Chen Y, Shi J. 2019. Exosome biochemistry and advanced nanotechnology for next‐generation theranostic platforms. Adv Mater. 31(2):1802896.
  • Yoon H, Ansong C, Adkins JN, Heffron F. 2011. Discovery of Salmonella virulence factors translocated via outer membrane vesicles to murine macrophages. Infect Immun. 79(6):2182–2192.
  • Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, Howarth M. 2012. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proceedings of the National Academy of Sciences of USA. 109(12). p. E690–E697.
  • Zariri A, van Dijken H, Hamstra H-J, van der Flier M, Vidarsson G, van Putten JP, Boog CJ, van den Dobbelsteen G, van der Ley P. 2013. Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles. Vaccine. 31(47):5585–5593.
  • Zeringer E, Barta T, Li M, Vlassov AV. 2015. 2015. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015(4):pdb.top074476.
  • Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, Mark MT, Molina H, Martin AB, Bojmar L, et al. 2018. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 20(3):332–343.
  • Zhang L, Wen Z, Lin J, Xu H, Herbert P, Wang X-M, Mehl JT, Ahl PL, Dieter L, Russell R, et al. 2016. Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification. Vaccine. 34(35):4250–4256.
  • Zhang Z, Wang C, Li T, Liu Z, Li L. 2014. Comparison of ultracentrifugation and density gradient separation methods for isolating Tca8113 human tongue cancer cell line-derived exosomes. Oncol Lett. 8(4):1701–1706.
  • Zhao L, Seth A, Wibowo N, Zhao C-X, Mitter N, Yu C, Middelberg AP. 2014. Nanoparticle vaccines. Vaccine. 32(3):327–337.
  • Ziegenbalg A, Prados-Rosales R, Jenny-Avital ER, Kim RS, Casadevall A, Achkar JM. 2013. Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker. Tuberculosis. 93(4):448–455.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.